spect and pet theranostics for glutamate in neurological disorder

Created using ChatSlide

This presentation explores the significance of glutamate theranostics in addressing neurological disorders. It highlights the clinical burden of conditions like stroke, epilepsy, ALS, and dementia, emphasizing the need for dynamic biomarkers. The discussion covers glutamate biology, the development of a theranostic framework, and the use of SPECT and PET imaging techniques. It also examines therapeutic pairings and clinical use cases, aiming to establish a roadmap for integrating research...